To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Thursday, July 29, 2021
FDA allows automatic 'generic' swap for brand-name insulin
It's the FDA's
first approval of an "interchangeable" biosimilar, a near-copy of
an injected biologic medicine that's manufactured inside living cells.
No comments:
Post a Comment